Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 known ✓ | P08588 | 1/20 | 0.33 |
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.33 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.33 |
| ▸ | ADRA1D known ✓ | P25100 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | APP | P05067 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
| ▸ | PDE4A | P27815 | 2/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taurine SCHEMBL27979344 | 0.84 | LMNA (0.61) | BLMLMNASLC6A6CYP2C19APP | |
| Taurine SCHEMBL30443868 | 0.84 | LMNA (0.61) | BLMLMNASLC6A6CYP2C19APP | |
| Taurine SCHEMBL4449607 | 0.83 | LMNA (0.82) | BLMLMNASLC6A6CYP2C19APP | |
| Taurine SCHEMBL27979203 | 0.83 | LMNA (0.58) | BLMLMNASLC6A6CYP2C19APP | |
| Taurine SCHEMBL27814625 | 0.80 | LMNA (0.78) | BLMLMNASLC6A6CYP2C19APP | |
| Taurine SCHEMBL3799348 | 0.80 | LMNA (0.61) | BLMLMNASLC6A6CYP2C19APP | |
| Taurine SCHEMBL23068 | 0.80 | — | — | |
| Taurine SCHEMBL30179154 | 0.80 | — | — | |
| Taurine SCHEMBL30191395 | 0.80 | — | — | |
| Taurine SCHEMBL42632 | 0.80 | BLM (1.00) | BLMLMNASLC6A6CYP2C19APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | HENKEL AG & CO. KGAA (DE) | 2009-12-10 | — | — | US | claimed |
| EP-1942877-A1 | ORGANOLEPTICALLY ACCEPTABLE IBUPROFEN ORAL DOSAGE FORMULATIONS, METHODS OF MAKING AND USING THE SAME | Teikoku Pharma USA, Inc. (US) | 2008-07-16 | — | — | EP | claimed |
| WO-2007055887-A1 | ORGANOLEPTICALLY ACCEPTABLE IBUPROFEN ORAL DOSAGE FORMULATIONS, METHODS OF MAKING AND USING THE SAME | TEIKOKU PHARMA USA, INC. (US) | 2007-05-18 | — | — | WO | claimed |
| US-20070098789-A1 | Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same | TEIKOKU PHARMA USA, INC. | 2007-05-03 | — | — | US | claimed |
| US-10722439-B2 | Hair care products | HENKEL AG & CO. KGAA (DE) | 2020-07-28 | — | — | US | disclosed |
| US-20200170912-A1 | COMPOSITION FOR THE CARE OF HUMAN HAIR | HENKEL AG & CO. KGAA (DE) | 2020-06-04 | — | — | US | disclosed |
| US-10328007-B2 | Hair straightening with carbocisteine | HENKEL AG & CO. KGAA (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20190021968-A1 | HAIR CARE PRODUCTS | HENKEL AG & CO. KGAA (DE) | 2019-01-24 | — | — | US | disclosed |
| US-20160296441-A1 | CONDITIONER FOR KERATIN FIBERS HAVING A SILICONE SUBSTITUTE | HENKEL AG & CO. KGAA (DE) | 2016-10-13 | — | — | US | disclosed |
| US-9456976-B2 | Hair treatment compositions comprising selected UV filters and selected complexes of acidic protein hydrolysates and basic fatty acid amidoamines | HENKEL AG & CO. KGAA (DE) | 2016-10-04 | — | — | US | disclosed |
| US-20160263000-A1 | HAIR STRAIGHTENING WITH CARBOCISTEINE | HENKEL AG & CO. KGAA (DE) | 2016-09-15 | — | — | US | disclosed |
| US-9248087-B2 | Anti-dandruff hair care products with selective active ingredients and a cationic keratin | HENKEL AG & CO. KGAA (DE) | 2016-02-02 | — | — | US | disclosed |
| US-20130125914-A1 | HAIR-CONDITIONING COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2013-05-23 | — | — | US | disclosed |
| US-20120204895-A1 | HAIR TREATMENT AGENTS COMPRISING POLYQUATERNIUM-72 | HENKEL AG & CO. KGAA (DE) | 2012-08-16 | — | — | US | disclosed |
| US-20120171149-A1 | AGENTS FOR TREATING KERATIN FIBERS, CONTAINING DIMETHYLSILANOL HYALURONATES AND GLYCEROL | HENKEL AG & CO. KGAA (DE) | 2012-07-05 | — | — | US | disclosed |
| US-20120121529-A1 | HAIR CONDITIONERS COMPRISING SELECTED CATIONIC SILICONES AND DIMETHICONE | HENKEL AG & CO. KGAA (DE) | 2012-05-17 | — | — | US | disclosed |
| US-20120114586-A1 | HAIR CONDITIONERS COMPRISING SELECTED CATIONIC SILICONES AND A B SERIES VITAMIN | HENKEL AG & CO. KGAA (DE) | 2012-05-10 | — | — | US | disclosed |
| US-20110268684-A1 | HAIR CONDITIONERS COMPRISING IMIDAZOLINES AND ESTER OILS | HENKEL AG & CO. KGAA (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20110033407-A1 | Hair Treatment Means With Cloudberry Extract | HENKEL AG & CO. KGAA (DE) | 2011-02-10 | — | — | US | disclosed |
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | HENKEL AG & CO. KGAA (DE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10722439-B2 | Hair care products | ACMSD, ARG1, NACA | ADRB2 3191/4885ADRB1 3342/4885ADRA2A 2943/4885 |
| US-20120204895-A1 | HAIR TREATMENT AGENTS COMPRISING POLYQUATERNIUM-72 | HTT, AAAS, HNMT | ADRB2 2386/4885ADRB1 2917/4885ADRA2A 2541/4885 |
| US-20120171149-A1 | AGENTS FOR TREATING KERATIN FIBERS, CONTAINING DIMETHYLSILANOL HYALURONATES AND GLYCEROL | KRT18, CD44, DSG1 | ADRB2 4220/4885ADRB1 4225/4885ADRA2A 3483/4885 |
| US-20110268684-A1 | HAIR CONDITIONERS COMPRISING IMIDAZOLINES AND ESTER OILS | PLIN3, PLIN5, FABP4 | ADRB2 2950/4885ADRB1 3229/4885ADRA2A 3326/4885 |
| US-20090304620-A1 | HAIR TREATMENT PRODUCTS COMPRISING POLYMERS | ASS1, SRM, COL1A1 | ADRB2 4142/4885ADRB1 4152/4885ADRA2A 2838/4885 |
| US-20120121529-A1 | HAIR CONDITIONERS COMPRISING SELECTED CATIONIC SILICONES AND DIMETHICONE | KRT18, DNER, DSC1 | ADRB2 4562/4885ADRB1 4518/4885ADRA2A 4581/4885 |
| US-20070098789-A1 | Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same | CYP2D6, CYP2A6, CYP2C9 | ADRB2 2328/4885ADRB1 2568/4885ADRA2A 1506/4885 |
| US-20110033407-A1 | Hair Treatment Means With Cloudberry Extract | KRT18, TUBB8, TUBB6 | ADRB2 3950/4885ADRB1 3821/4885ADRA2A 4173/4885 |
| US-20190021968-A1 | HAIR CARE PRODUCTS | ACMSD, ARG1, NACA | ADRB2 3019/4885ADRB1 3111/4885ADRA2A 2785/4885 |
| US-10328007-B2 | Hair straightening with carbocisteine | KRT18, PRKDC, PRKACG | ADRB2 4292/4885ADRB1 4528/4885ADRA2A 4335/4885 |
| US-20120114586-A1 | HAIR CONDITIONERS COMPRISING SELECTED CATIONIC SILICONES AND A B SERIES VITAMIN | KRT18, PROC, BTD | ADRB2 4179/4885ADRB1 4217/4885ADRA2A 4315/4885 |
| US-20160296441-A1 | CONDITIONER FOR KERATIN FIBERS HAVING A SILICONE SUBSTITUTE | KRT18, CUTA, DNER | ADRB2 4162/4885ADRB1 4145/4885ADRA2A 4388/4885 |
| US-20130125914-A1 | HAIR-CONDITIONING COMPOSITIONS | SHH, HDAC10, NR5A1 | ADRB2 1332/4885ADRB1 1346/4885ADRA2A 999/4885 |
| US-20200170912-A1 | COMPOSITION FOR THE CARE OF HUMAN HAIR | POLR1C, KRT18, SLC27A1 | ADRB2 2079/4885ADRB1 2240/4885ADRA2A 2828/4885 |
| US-20160263000-A1 | HAIR STRAIGHTENING WITH CARBOCISTEINE | KRT18, PRKDC, PRKACG | ADRB2 4292/4885ADRB1 4528/4885ADRA2A 4335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.